Va Tech Wabag Ltd Q1 FY27 Earnings Call: Record Order Intake of Rs. 3,400 Cr, Reaffirms 15-20% Revenue Guidance

Va Tech Wabag Ltd held its Q1 FY27 earnings call on August 12, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Record Revenue, PAT Growth and Order Intake

• Consolidated revenue of Rs.887 Cr in Q1 FY2026-2027, up 20.8% YoY, exceeding the guided 15–20% range for the fiscal year.
• Consolidated EBITDA of Rs.116 Cr (margin >13%), growing 21.7% YoY; PAT of Rs.90 Cr (margin 10.2%), up ~37% YoY.
• Standalone revenue of Rs.739 Cr (>15% YoY growth), EBITDA Rs.105 Cr (~21% YoY), PAT Rs.79 Cr (>30% YoY).
• Record order intake of Rs.3,400 Cr in Q1 FY2026-2027 (EPC Rs.2,960 Cr, O&M Rs.470 Cr), with 77% from international markets.
• Order book reached Rs.19,400 Cr (~$1.8B), >4x revenue, split 66% EPC and 34% O&M, balanced between India and international.
• Net cash balance of Rs.965 Cr (ex-HAM), marking the 14th consecutive quarter of net cash positivity; ROCE at 19.6%, ROE at 16%.
• Operating margins excluding forex declined from 15.8% (Q1 FY2025-2026) to 8.9% (Q1 FY2026-2027), but management considers forex fully operational given 52% of revenues from international geographies.

Rs.19,400 Cr Backlog with $2–3B Bid Pipeline

• Order book adjusted to Rs.19,400 Cr in Q1 FY2026-2027 after management removed Rs.600 Cr of framework orders (previously reported in Q4 FY2025-2026) that were not yet effective despite being signed.
• Total bid pipeline estimated at $2–3B (~Rs.20,000–Rs.25,000 Cr) across Middle East, Africa, and India as of Q1 FY2026-2027, tracked over a 12–18 month lifecycle.
• India domestic pipeline estimated at $1–1.5B (Q1 FY2026-2027); management confirmed no specific order inflow target for FY2026-2027 but expressed confidence in maintaining the >4x backlog multiple.
• Middle East constitutes ~35–40% of the current order backlog; the overall India/international split is roughly 50–50.
• Key wins in Q1 FY2026-2027: 60 MLD SWRO desalination plant in Kuwait (maiden project, with O&M component), third phase of 60 MLD Ajman sewage treatment plant in UAE (Wabag-led consortium), and Hadda ISTP project (preferred EPC partner).
• Order backlog execution expected over 36 months; international EPC projects cycle in 24–30 months, while domestic Indian projects take 36 months or more. O&M backlog provides 7–10 years of recurring revenues.

EBITDA Guidance Intact, Working Capital Improves

• EBITDA margin guidance maintained at 13–15% over the medium term (3–5 years, through FY2030-2031); management expects FY2026-2027 margins in the 13–14% range due to current project mix, improving toward 15% with economies of scale.
• Forex gains in Q1 FY2026-2027 are transactional (not translational), akin to the forex loss in Q1 FY2025-2026; management advises analysts not to adjust them out of operational results, as 52% of revenues come from international geographies.
• Including forex, margins remained above 13% in Q1 FY2026-2027 and grew year-on-year; management cited no material impact from the Middle East war on FY2026-2027 guidance.
• Net working capital at 108 days (3–3.5 months), considered normal for a construction company at 15–20% growth; working capital days have sequentially improved over the last 3–4 years as the international order mix increased.
• TSGENCO receivable of Rs.140 Cr remains sub-judice under arbitration; management noted a favorable Supreme Court verdict provides assurance of recoverability but declined to provide a timeline for resolution.
• Currency exposure is naturally hedged via imports from third countries (Europe, Japan, US); residual revenue-cost mismatch is covered through PCFC, leaving no significant unhedged cash positions.

125 IP Rights, Asset-Light Model, Global Cost Advantage

• Company holds 125 IP rights developed internally, including a proprietary patented flat-walls technology for filtration stages before reverse osmosis that reduces filter sizing and offers a cost advantage over competitors.
• Four-decade track record in Middle East and Africa with a workforce based in Turkey, Egypt, and India, delivering "European quality at Indian prices" — cited by management as a key differentiator against European rivals.
• 7,000 plants built globally provide proprietary data for value engineering and competitive bidding; R&D focus areas include ceramic membranes, de-ammonification, PFAS treatment, and membrane crystallization (specific spend not disclosed).
• Asset-light model with no CAPEX requirements for taking on orders; the company remains selective, accepting only orders meeting predefined thresholds for margins and cash flows.
• International orders invoiced in USD, Euro, or USD-pegged currencies (SAR, Qatari Riyal, Kuwaiti Dinar), avoiding non-convertible currencies to eliminate foreign exchange risk; local currency used only for local expenditures.

Industrial Mix Reshaping, O&M Grows 7%; Greenfield Sectors Emerge

• Industrial segment at 12–13% of order backlog (Q1 FY2026-2027), down from >20% two-three years ago; historically contributed ~30% of revenues (FY2024-2025). Management "targets raising the industrial order mix to 20-25% over 3-7 years", with oil & gas accounting for 90% of the industrial pipeline.
• O&M revenue grew 7% YoY in Q1 FY2026-2027; management expects more projects to enter O&M phase (Ghaziabad, Digha, Kankinara completed) over a 2–3 year horizon, not a single year.
• Perur desalination project (Chennai) reached 75% completion in Q1 FY2026-2027, with 80–85% of concreting done and 1,00,000 cubic meters completed — a record for a single Wabag project; funded by JICA.
• New growth avenues identified: solar PV, semiconductor, data centers, and green hydrogen — management views these as "decadal opportunities requiring a long-term perspective". Over the next 12–18 months (through FY2027-2028), only one or two selective orders expected; meaningful contribution over a 3–5 year horizon (through ~FY2030-2031).
• Breakthrough orders already secured in adjacent areas: Renusys (ultrapure water), Indosol Solar (desalination), and Ghaziabad CBG.
• Saudi Arabia: management cited "2027 declared 'year of water' by Saudi" as a driver; half a dozen active inquiries across government (Sharaka/SWPC) and private entity tenders.

15–20% Revenue Growth Reaffirmed; Vriddhi 2.0 Strategy in Development

• Revenue growth guidance of 15–20% for FY2026-2027 reaffirmed, with Q1 already delivering 21% growth; management stated "there is no bottleneck to higher growth" and the guidance is conservative.
• EBITDA margin guidance of 13–15% over the medium term (through FY2030-2031); FY2026-2027 expected at 13–14% due to project mix, improving toward 15% over time with scale.
• Management working on next long-term strategy ("Vriddhi 2.0"), to be presented at the annual investor meet for FY2026-2027, expected in May 2027.
• EP vs EPC mix: management targets 10–20% of revenues from EP (engineering and procurement) projects on a multi-year basis; Q1 FY2026-2027 majority was EPC, but recent large orders (Ajman, Doha) tilt toward EP/design-build, which carries better margins.
• No specific numeric guidance for FY2027-2028 was provided; management expressed confidence that sustained delivery will drive rerating, responding to analyst aspirational market-cap targets of Rs.15,000–Rs.20,000 Cr by focusing on operational performance.
• Risks noted: TSGENCO recovery timeline remains uncertain; Middle East geopolitical tensions are monitored but have not materially impacted guidance; the company has no current presence in South America but is monitoring the region.